Fed. Circ. OKs Mixed Ruling For Lundbeck In Trintellix IP Case
The Federal Circuit has backed a decision that a slew of generic-drug makers don't infringe two of H. Lundbeck's patents on antidepressant drug Trintellix, while also affirming a decision that Lupin...To view the full article, register now.
Already a subscriber? Click here to view full article